EUVIMEDEUVIMED entdecken
Crossref

Applications of Digital Polymerase Chain Reaction (dPCR) in Molecular and Clinical Testing

Lauren M Wainman, Shivaprasad H Sathyanarayana iD, Joel A Lefferts iD

The Journal of Applied Laboratory Medicine · 2024

DOI: 10.1093/jalm/jfad103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, 2024. Verfasst von Lauren M Wainman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Clinical Genomics and Advanced Technology (CGAT), Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center,…. Hauptthemen laut MEDLINE: Prenatal Diagnosis, Nucleic Acids. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Digital polymerase chain reaction (dPCR) is an accurate and sensitive molecular method that can be used in clinical diagnostic, prognostic, and predictive tests. The key component of the dPCR method is the partitioning of a single reaction into many thousands of droplets, nanochannels or other nano- or picoliter-sized reactions. This results in high enough sensitivity to detect rare nucleic acid targets and provides an absolute quantification of target sequences or alleles compared to other PCR-based methods. Content An increasing number of dPCR platforms have been introduced commercially in recent years and more are being developed. These platforms differ in the method of partitioning, degree of automation, and multiplexing capabilities but all can be used in similar ways for sensitive and highly accurate quantification of a variety of nucleic acid targets. Currently, clinical applications of dPCR include oncology, microbiology and infectious disease, genetics, and prenatal/newborn screening. Commercially available tests for clinical applications are being developed for variants with diagnostic, prognostic, and therapeutic significance in specific disease types. Summary The power of dPCR technology relies on the partitioning of the reactions and results in increased sensitivity and accuracy compared to qPCR. More recently, the sensitivity of dPCR has been applied to the detection of known variants in cell-free DNA and circulating tumor DNA. Future clinical applications of dPCR include liquid biopsy, treatment resistance detection, screening for minimal residual disease, and monitoring allograft engraftment in transplanted patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prenatal DiagnosisNucleic AcidsPregnancyFemaleInfant, NewbornHumansPolymerase Chain Reaction

Substanzen

Nucleic Acids

Autor:innen und Institutionen

  • Laboratory for Clinical Genomics and Advanced Technology (CGAT), Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, United States.

ORCID-Profile: Shivaprasad H Sathyanarayana, Joel A Lefferts

Zitieren

APA

Wainman, L. M., Sathyanarayana, S. H., & Lefferts, J. A. (2024). Applications of Digital Polymerase Chain Reaction (dPCR) in Molecular and Clinical Testing. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfad103

Vancouver

Wainman LM, Sathyanarayana SH, Lefferts JA. Applications of Digital Polymerase Chain Reaction (dPCR) in Molecular and Clinical Testing. The Journal of Applied Laboratory Medicine. 2024. doi:10.1093/jalm/jfad103

BibTeX
@article{Wainman2024,
  author = {Wainman, Lauren M and Sathyanarayana, Shivaprasad H and Lefferts, Joel A},
  title = {Applications of Digital Polymerase Chain Reaction (dPCR) in Molecular and Clinical Testing},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2024},
  doi = {10.1093/jalm/jfad103}
}
Kostenlos starten →